{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:49:54Z","timestamp":1788796194547,"version":"build-2803163510"},"reference-count":27,"publisher":"Bioscientifica","issue":"2","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":361,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Patients are increasingly using and requesting LT4\/LT3 combination treatment for persistent hypothyroid symptoms, but the efficacy and side effects of long-term therapy remain largely unexplored. This study aimed to describe the patient group experiencing a long-lasting impact of LT4\/LT3 and evaluate their quality of life (QoL) and hypothyroid symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We performed a cross-sectional study of 66 hypothyroid patients who had previously initiated LT4\/LT3 combination therapy. The patients were grouped by current treatment into patients still receiving LT4\/LT3 treatment (T3 responders) and patients who had discontinued LT3 treatment due to lack of effect (T3 non-responders). ThyPRO was used to evaluate QoL, and a validated symptom score was used to assess hypothyroid symptoms. The paper describes a real-life study that depicts unsatisfied patients as they are met in an outpatient clinic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The participants had a median age of 56 and had initiated LT4\/LT3 combination therapy 5.4 years ago. Fifty-four patients still received LT4\/LT3 therapy and 12 patients had discontinued LT3 treatment due to lack of effect. Patients in the T3 responder group experienced a QoL comparable to the background population. Surprisingly, symptom scores in the T3 responder group were at the same levels as seen in Danish females with overt hypothyroidism. Thyoid stimulating hormone (TSH) in the T3 responder group was less than 0.4 mU\/L in 38% of patients, indicating overtreatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LT4\/LT3 treatment was well-tolerated with no side effects and high QoL, but patients still experienced many symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-24-0275","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:06:09Z","timestamp":1740139569000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":3,"title":["Long-term outcomes of LT4\/LT3 combination treatment for persistent hypothyroid symptoms"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9540-4950","authenticated-orcid":true,"given":"Birte","family":"Nygaard","sequence":"first","affiliation":[{"name":"Herlev Hospital, Department of Endocrinology 1 , ,","place":["Herlev, Denmark"]},{"name":"University of Copenhagen Faculty of Health and Medical Sciences, Department of Clinical Medicine 2 , ,","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5882-2547","authenticated-orcid":true,"given":"Christian Zinck","family":"Jensen","sequence":"additional","affiliation":[{"name":"Herlev Hospital, Department of Endocrinology 1 , ,","place":["Herlev, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Jorsal","sequence":"additional","affiliation":[{"name":"Division of Translational Endocrinology, Department of Endocrinology, and Internal Medicine 3 , ,","place":["Herlev, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarke R\u00f8ssnes","family":"Medici","sequence":"additional","affiliation":[{"name":"Herlev Hospital, Department of Endocrinology 1 , ,","place":["Herlev, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi","family":"Steffensen","sequence":"additional","affiliation":[{"name":"Aalborg Universitetshospital, Department of Immunology, Aalborg University Hospital 4 , , ,","place":["Aalborg, Nordjylland, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Carle","sequence":"additional","affiliation":[{"name":"Aalborg University Hospital, Department of Endocrinology 5 , ,","place":["Aalborg, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe Lerche","family":"la Cour","sequence":"additional","affiliation":[{"name":"Hvidovre Hospital, Department of Endocrinology, Copenhagen University 6 , ,","place":["Hvidovre, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"2026070712560294500_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000339444","article-title":"2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism","volume":"1","author":"Wiersinga","year":"2012","journal-title":"Eur Thyroid J"},{"key":"2026070712560294500_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000512970","article-title":"Evidence-based use of levothyroxine\/liothyronine combinations in treating hypothyroidism: a consensus document","volume":"10","author":"Jonklaas","year":"2021","journal-title":"Eur Thyroid J"},{"key":"2026070712560294500_bib3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2265.2008.03521.x","article-title":"A paradoxical difference in relationship between anxiety, depression and thyroid function in subjects on and not on T4: findings from the HUNT study","volume":"71","author":"Panicker","year":"2009","journal-title":"Clin Endocrinol"},{"key":"2026070712560294500_bib4","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1210\/jc.2014-1407","article-title":"Hypothyroidism is a predictor of disability pension and loss of labor market income: a Danish register-based study","volume":"99","author":"Thvilum","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712560294500_bib5","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1530\/EJE-09-0542","article-title":"Effect of combination therapy with thyroxine (T4) and 3,5,3\u2019-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study","volume":"161","author":"Nygaard","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2026070712560294500_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cen.14742","article-title":"Combined T4 + T3 therapy versus T4 monotherapy effect on psychological health in hypothyroidism: a systematic review and meta-analysis","volume":"97","author":"Lan","year":"2022","journal-title":"Clin Endocrinol"},{"key":"2026070712560294500_bib7","doi-asserted-by":"crossref","first-page":"e4400","DOI":"10.1210\/clinem\/dgab478","article-title":"Comparative effectiveness of levothyroxine, desiccated thyroid extract, and levothyroxine+liothyronine in hypothyroidism","volume":"106","author":"Shakir","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712560294500_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ejendo\/lvad172","article-title":"Randomized double-blind placebo-controlled trial on levothyroxine and liothyronine combination therapy in totally thyroidectomized subjects: the LEVOLIO study","volume":"190","author":"Brigante","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2026070712560294500_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/cen.14340","article-title":"Patient satisfaction and quality of life in hypothyroidism: An online survey by the british thyroid foundation","volume":"94","author":"Mitchell","year":"2021","journal-title":"Clin Endocrinol"},{"key":"2026070712560294500_bib10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/cen.13052","article-title":"Liothyronine use in a 17-year observational population-based study \u2013 the tears study","volume":"85","author":"Leese","year":"2016","journal-title":"Clin Endocrinol"},{"key":"2026070712560294500_bib11","article-title":"Assessing the risk of atrial fibrillation in hypothyroid women prescribed with liothyronine: a retrospective cohort study n.d","author":"la Cour"},{"key":"2026070712560294500_bib12","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1089\/thy.2020.0388","article-title":"Liothyronine use in hypothyroidism and its effects on cancer and mortality","volume":"31","author":"Planck","year":"2021","journal-title":"Thyroid"},{"key":"2026070712560294500_bib13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1089\/thy.2021.0634","article-title":"Heart failure and stroke risks in users of liothyronine with or without levothyroxine compared with levothyroxine alone: a propensity score-matched analysis","volume":"32","author":"Yi","year":"2022","journal-title":"Thyroid"},{"key":"2026070712560294500_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000454878","article-title":"Neither baseline nor changes in serum triiodothyronine during levothyroxine\/liothyronine combination therapy predict a positive response to this treatment modality in hypothyroid patients with persistent symptoms","volume":"6","author":"Medici","year":"2017","journal-title":"Eur Thyroid J"},{"key":"2026070712560294500_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000490383","article-title":"Levothyroxine\/liothyronine combination therapy and quality of life: is it all about weight loss?","volume":"7","author":"Michaelsson","year":"2018","journal-title":"Eur Thyroid J"},{"key":"2026070712560294500_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443609","article-title":"High level of agreement between electronic and paper mode of administration of a thyroid-specific patient-reported outcome, ThyPRO","volume":"5","author":"Rasmussen","year":"2016","journal-title":"Eur Thyroid J"},{"key":"2026070712560294500_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-09-0521","article-title":"Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO","volume":"162","author":"Watt","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2026070712560294500_bib18","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1089\/thy.2016.0044","article-title":"Quality-of-Life impairments persist six months after treatment of Graves\u2019 hyperthyroidism and toxic nodular goiter: a prospective cohort study","volume":"26","author":"Cramon","year":"2016","journal-title":"Thyroid"},{"key":"2026070712560294500_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1530\/EJE-14-0481","article-title":"Hypothyroid symptoms and the likelihood of overt thyroid failure: a population-based case\u2013control study","volume":"171","author":"Carl\u00e9","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2026070712560294500_bib20","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.amjmed.2016.06.013","article-title":"Hypothyroid symptoms fail to predict thyroid insufficiency in old people: a population-based case-control study","volume":"129","author":"Carl\u00e9","year":"2016","journal-title":"Am J Med"},{"key":"2026070712560294500_bib21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.amjmed.2021.03.009","article-title":"Does subclinical hypothyroidism add any symptoms? Evidence from a Danish population-based study","volume":"134","author":"Carl\u00e9","year":"2021","journal-title":"Am J Med"},{"key":"2026070712560294500_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/thy.2006.0191","article-title":"Age modifies the pituitary TSH response to thyroid failure","volume":"17","author":"Carl\u00e9","year":"2007","journal-title":"Thyroid"},{"key":"2026070712560294500_bib23","article-title":"E: Use of T3-containing treatment for hypothyroidism","author":"Papini"},{"key":"2026070712560294500_bib24","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1089\/thy.2018.0325","article-title":"Physician choice of hypothyroidism therapy: influence of patient characteristics","volume":"28","author":"Jonklaas","year":"2018","journal-title":"Thyroid"},{"key":"2026070712560294500_bib25","article-title":"Socioeconomic influence on treatment with liothyronine and desiccated thyroid extract in Denmark","volume":"11","author":"la Cour","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"2026070712560294500_bib26","first-page":"104","article-title":"Prevalence and predictors of adequate treatment of overt hypothyroidism \u2013 a population-based study","volume":"21","author":"Lindg\u00e5rd Nielsen","year":"2022","journal-title":"EXCLI J"},{"key":"2026070712560294500_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/thy.2022.0641","article-title":"Hypothyroidism and somatization: results from E-mode patient self-assessment of thyroid therapy, a cross-sectional, international online patient survey","volume":"33","author":"Perros","year":"2023","journal-title":"Thyroid"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/14\/2\/ETJ-24-0275.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/14\/2\/ETJ-24-0275.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-24-0275\/36935\/etj-24-0275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-24-0275\/36935\/etj-24-0275.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:24:39Z","timestamp":1783445079000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/14\/2\/e240275\/4630\/Long-term-outcomes-of-LT4-LT3-combination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-24-0275","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"article-number":"e240275"}}